Mark Cuban read­ies to fight Hu­mi­ra's megablock­buster fran­chise next month

Mark Cuban’s Cost Plus Drugs Com­pa­ny said to­day that it’s to com­pete with Ab­b­Vie’s mul­ti-bil­lion-dol­lar Hu­mi­ra fran­chise by en­ter­ing the biosim­i­lar fray along­side more than …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER